Breast tumors escape endocrine therapy by ER-independent mechanisms triggered by the coordinated activities of HER2/HER3 and deacetylated FOXA1
Gilfillan, S.; Wang, S.; Katika, M. R.; Norum, J. H.; Bergholtz, H.; Fiorito, E.; Nordhagen, S.; Sharma, Y.; Singh, S.; Somisety, V. S.; Fosdahl, A.-M.; Nord, S.; Engebraaten, O.; Lingjaerde, O. C.; Borresen-Dale, A.-L.; Sahlberg, K. K.; Sorlie, T.; Bellet, M.; Lopez-Aviles, S.; Hurtado-Rodriguez, A.
Show abstract
Hormone-resistance in ER positive breast cancer is associated with high HER2 activity. Yet, the interplay between HER2 and FOXA1 in hormone resistant tumors is not elucidated. Now, we demonstrate that hormone resistant tumors have increased HER2 expression and that FOXA1 mediates the signals of HER2/3 in an Estrogen Receptor independent manner. Our in vitro and in vivo experiments reveal that HER2/HER3 triggers FOXA1 binding at chromatin regions of ER-regulated genes associated with poor prognosis, facilitating their expression and leading to ER-independent growth. Furthermore, our study supports that FOXA1 acetylated by the acetyltransferase EP300 is retained at ER chromatin regions, which enables ER function. By contrast, HER2/3 activation hinders FOXA1 acetylation and facilitates FOXA1 binding at non-ER interacting regions enriched towards poor prognosis genes. Moreover, FOXA1 deacetylation confers insensitivity to anti-ER drugs inhibitory effect in ER positive cells. These results elucidate how post-translational modifications of FOXA1 control transcription independently of ER in hormone-resistant tumors with enhanced HER2/3 signaling.
Matching journals
The top 5 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Targeting STAT3 signalling using stabilised sulforaphane (SFX-01) inhibits endocrine resistant stem-like cells in ER-positive breast cancer 96%
- METTL3 regulates breast cancer-associated alternative splicing switches 95%
- Loss of EIF4G2 Mediates Aggressiveness in Distinct Human Endometrial Cancer Subpopulations with Poorer Survival Outcome in Patients 95%
Similar papers in this journal
- Loss of chromosome cytoband 13q14.2 orchestrates breast cancer pathogenesis and drug response 96%
- Chromatin accessibility landscape and active transcription factors in primary human invasive lobular and ductal breast carcinomas 96%
- Cooperative NF-κB and Notch1 signaling promotes macrophage-mediated MenaINV expression in breast cancer 95%
Similar papers in this journal
- Hormonal regulation of Semaphorin 7a in ER+ breast cancer drives therapeutic resistance 96%
- STAT3 and GR cooperate to drive basal-like triple negative breast cancer gene expression and proliferation. 95%
- Estrogen receptor alpha mutations in breast cancer cells cause gene expression changes through constant activity and through secondary effects 95%
Similar papers in this journal
- Intracellular Retention of Estradiol is Mediated by GRAM Domain Containing Protein ASTER-B in Breast Cancer Cells 96%
- Identifying and targeting key driver genes for collagen production within the 11q13/14 breast cancer amplicon 94%
- Mediator of DNA damage checkpoint 1 (MDC1) is a novel estrogen receptor co-regulator in invasive lobular carcinoma of the breast 94%
Similar papers in this journal
- CRISPR/Cas9 screen reveals a role of purine synthesis for estrogen receptor α activity and tamoxifen resistance of breast cancer cells 96%
- Aneuploidy and deregulated DNA damage response define haploinsufficiency in breast tissues of BRCA2 mutation carriers 94%
- HIRA loss transforms FH-deficient cells 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.